Addex Therapeutics Ltd Capital Reinvestment Ratio
Addex Therapeutics Ltd capital reinvestment ratio. Addex Therapeutics Ltd (ADXN) has a Capital Reinvestment Ratio of 0.07x as of December 2020, meaning it reinvests 0% of its operating cash flow ($704.85K) in capital expenditures ($48.09K). Check ADXN cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Addex Therapeutics Ltd (2018–2018)
Capital reinvestment ratio of Addex Therapeutics Ltd from 2018 to 2018. This chart tracks Addex Therapeutics Ltd's Capital Reinvestment Ratio across 1 annual periods. Also explore ADXN net asset momentum to track the company's year-over-year net asset growth rate.
Addex Therapeutics Ltd Capital Reinvestment Ratio by Year (2018–2018)
Addex Therapeutics Ltd capital reinvestment ratio by year from 2018 to 2018. For the full cash flow conversion analysis, see ADXN cash flow metrics.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2018 | 0.01x | $1.75 Million | $9.05K | — |